An April 2026 study in the Canadian Medical Association Journal (CMAJ) projects that 254,100 people in Canada will be diagnosed with cancer and 87,900 will die from it in 2026.
While cancer incidence and mortality rates are declining, high patient volumes persist due to an aging and growing population — with Lung, Breast, Prostate, and Colorectal cancers constituting 47% of new cases.
Key Findings from 2026 Projections noted in the CMAJ article:
- Leading Cancers: Lung (32,900); Breast (32,700); Prostate (29,300); and Colorectal (25,300) are the most common diagnoses.
- Rising Trends: Concerning rises in Cervical, Head & Neck, Pancreatic and Uterine cancers are noted; with Uterine cancer mortality expected to be 50% higher than the mid-2000s.
- Mortality: Cancer remains the leading cause of death in Canada.
- Demographic Shift: Cancer rates are rising among Canadians under 50, particularly for Breast, Colorectal, Testicular, and Uterine cancers.
- Prostate Focus: Prostate cancer occurs in one in eight males in Canada, with research focussing on overcoming treatment resistance.
Key Takeaways on Care and Prevention:
- Progress: Despite rising numbers, age-standardized mortality rates are declining due to better prevention, screening, and treatment.
- Screening Gaps: Too few people are participating in screening programs, particularly in Ontario where — 800,000 women in their 40s have not had a mammogram.
- Future Focus: The Pan-Canadian Cancer Data Strategy is being implemented to address these challenges.
The study emphasizes that while per-person risk is decreasing, the sheer volume of cases requires ongoing innovation and investment in care.
Summarized from the CMAJ article, April 2026